scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1103128391 |
P356 | DOI | 10.1186/S13287-018-0827-Z |
P932 | PMC publication ID | 5883535 |
P698 | PubMed publication ID | 29615103 |
P50 | author | Wei Wei | Q88257310 |
P2093 | author name string | Baolin Wang | |
Min Chen | |||
Rongchao Ying | |||
Xiaoping Zou | |||
Xuan Tao | |||
Mingyang Sun | |||
Wenjie Su | |||
Xiaohu Meng | |||
P2860 | cites work | HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 | Q24306365 |
Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis | Q28084366 | ||
Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts | Q28576792 | ||
Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling | Q30583559 | ||
Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET | Q33676193 | ||
High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction | Q50438494 | ||
Simvastatin improves disturbed endothelial barrier function. | Q50514775 | ||
Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction. | Q50885481 | ||
Six-month feeding of low-dose fish oil decreases vascular expression of high mobility group box1 and receptor for advanced glycation end-products in rat chronic allograft vasculopathy. | Q50906405 | ||
Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia. | Q51061293 | ||
Vascular smooth muscle cell apoptosis promotes transplant arteriosclerosis through inducing the production of SDF-1α. | Q53154105 | ||
Blockade of Extracellular HMGB1 Suppresses Xenoreactive B Cell Responses and Delays Acute Vascular Xenogeneic Rejection. | Q53516911 | ||
Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation | Q79618736 | ||
High-mobility group box 1 accelerates early acute allograft rejection via enhancing IL-17+ γδ T-cell response | Q87070945 | ||
HMGB1-Mediated Early Loss of Transplanted Islets Is Prevented by Anti-IL-6R Antibody in Mice | Q87438019 | ||
Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction | Q87792956 | ||
HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs | Q88196311 | ||
Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study. | Q33722670 | ||
Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function | Q34763616 | ||
Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model | Q35879079 | ||
Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery | Q35982936 | ||
Transfer of bone-marrow-derived mesenchymal stem cells influences vascular remodeling and calcification after balloon injury in hyperlipidemic rats | Q35991244 | ||
Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. | Q36067773 | ||
Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye. | Q36459369 | ||
Differentiation of multipotent vascular stem cells contributes to vascular diseases | Q36511596 | ||
Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study | Q37022116 | ||
HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. | Q37582089 | ||
Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification | Q38210159 | ||
The Role of HMGB1 in Cardiovascular Biology: Danger Signals | Q38525463 | ||
Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy. | Q38569013 | ||
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells | Q38571488 | ||
The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation. | Q38789882 | ||
Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα(+) mesenchymal cells from bone marrow. | Q38998975 | ||
Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease | Q39401060 | ||
Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice. | Q39475922 | ||
Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material | Q39549075 | ||
In vivo IL13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants. | Q39908369 | ||
Local delivery of HMGB1 in gelatin sponge scaffolds combined with mesenchymal stem cell sheets to accelerate fracture healing | Q41091893 | ||
Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury | Q41101236 | ||
Endothelial‑like cells differentiated from mesenchymal stem cells attenuate neointimal hyperplasia after vascular injury | Q41959178 | ||
Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development | Q42832475 | ||
HMGB1 and injury amplification. | Q43112066 | ||
High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway | Q45247245 | ||
The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation | Q47345486 | ||
Differentiation of Vascular Stem Cells Contributes to Ectopic Calcification of Atherosclerotic Plaque | Q48247931 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P921 | main subject | mesenchymal stem cell | Q1922379 |
P304 | page(s) | 85 | |
P577 | publication date | 2018-04-03 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis | |
P478 | volume | 9 |
Q64055491 | A Rat Model of Radiation Vasculitis for the Study of Mesenchymal Stem Cell-Based Therapy |
Q64100579 | HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation |
Q92956342 | High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway |
Q92088123 | High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injury |
Q92258451 | Mesenchymal Stem Cell Migration and Tissue Repair |
Q90434755 | Perivascular Adipose Tissue Regulates Vascular Function by Targeting Vascular Smooth Muscle Cells |
Q90236393 | S100B is required for maintaining an intermediate state with double-positive Sca-1+ progenitor and vascular smooth muscle cells during neointimal formation |
Q91863929 | Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells |
Q89500866 | Transcriptional landscape of myogenesis from human pluripotent stem cells reveals a key role of TWIST1 in maintenance of skeletal muscle progenitors |
Search more.